Form
Fill Out The Form To Begin Your Download
Our new poster presented at ACS Spring 2023 showcases Curapath's bioinspired PEG alternatives with shielding properties. Our portfolio includes polypeptoid polysarcosine (PSar), which has similar properties and versatility for (bio)conjugation. Our alternatives have been produced and scaled up in technical batches and GMP conditions, demonstrating batch-to-batch reproducibility and QC compliance. Download the poster to learn more about our PEG-free alternatives.
Support for Your Therapeutic Program
Contact a Chemist Today
Contact Us, and we can discuss your specific therapeutic program and how Curapath can help build the right solution to advance your unique drug.